Charles River Labs Intl buy UBS Group AG
Start price
15.02.24
/
50%
€227.80
Target price
15.02.25
€269.47
Performance (%)
-5.58%
Price
26.07.24
€215.10
Summary
This prediction is currently active. With a performance of -5.58%, the BUY prediction by UBS_Group_AG is trending in the wrong direction. This prediction currently runs until 15.02.25. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Charles River Labs Intl | 7.175% | 7.175% |
iShares Core DAX® | 1.280% | 1.027% |
iShares Nasdaq 100 | -2.457% | -4.650% |
iShares Nikkei 225® | -2.006% | -2.091% |
iShares S&P 500 | -0.662% | -1.246% |
Comments by UBS_Group_AG for this prediction
In the thread Charles River Labs Intl diskutieren
Charles River Laboratories International, Inc. (NYSE: CRL) had its price target raised by analysts at UBS Group AG from $270.00 to $290.00. They now have a "buy" rating on the stock.
Ratings data for CRL provided by MarketBeat
Stopped prediction by UBS_Group_AG for Charles River Labs Intl
Charles River Labs Intl
Start price
Target price
Perf. (%)
€158.95
09.11.23
09.11.23
€201.48
09.11.24
09.11.24
35.33%
26.07.24
26.07.24